Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Claggett

Showing results (161-170 of 361) with videos related to

Pageof 37
Sort By:
Scientific Reports|June 20, 2024
Cardioprotective effects of early versus late initiated antiretroviral treatment in adolescents with perinatal HIV-1 infectionItai M Magodoro, Carlos E Guerrero-Chalela, Brian Claggett, et al.
Circulation|June 23, 2017
Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist)Sheila M Hegde, Brian Claggett, Amil M Shah, et al.
JACC. Heart Failure|September 13, 2020
Associations Between Depressive Symptoms and HFpEF-Related OutcomesAlvin Chandra, Michael A D Alcala, Brian Claggett, et al.
International Journal of Cardiology|June 19, 2023
Left ventricular remodeling and its correlates among adolescents with perinatally acquired HIV in South AfricaItai M Magodoro, Carlos E Guerrero-Chalela, Brian Claggett, et al.
Circulation|September 12, 2014
Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities StudySusan Cheng, Brian Claggett, Andrew W Correia, et al.
European Journal of Heart Failure|February 7, 2015
Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fractionAdriaan A Voors, Mauro Gori, Licette C Y Liu, et al.
Diabetes Care|July 11, 2022
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker StudyHertzel C Gerstein, Sibylle Hess, Brian Claggett, et al.
European Journal of Heart Failure|November 29, 2019
Left atrial structure and function and the risk of death or heart failure in atrial fibrillationRiccardo M Inciardi, Robert P Giugliano, Brian Claggett, et al.
The New England Journal of Medicine|April 27, 2017
Spironolactone Metabolites in TOPCAT - New Insights into Regional VariationSimon de Denus, Eileen O'Meara, Akshay S Desai, et al.
European Journal of Heart Failure|May 23, 2026
Cardiovascular events after acute myocardial infarction complicated by low ejection fraction and/or congestion: a landmark analysis of the PARADISE-MI trialJacinthe Boulet, Jean-Lucien Rouleau, Mark Petrie, et al.
Pageof 37

Showing results (161-170 of 361) with videos related to

Sort By:
Pageof 37
Scientific Reports|June 20, 2024
Cardioprotective effects of early versus late initiated antiretroviral treatment in adolescents with perinatal HIV-1 infectionItai M Magodoro, Carlos E Guerrero-Chalela, Brian Claggett, et al.
Circulation|June 23, 2017
Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist)Sheila M Hegde, Brian Claggett, Amil M Shah, et al.
JACC. Heart Failure|September 13, 2020
Associations Between Depressive Symptoms and HFpEF-Related OutcomesAlvin Chandra, Michael A D Alcala, Brian Claggett, et al.
International Journal of Cardiology|June 19, 2023
Left ventricular remodeling and its correlates among adolescents with perinatally acquired HIV in South AfricaItai M Magodoro, Carlos E Guerrero-Chalela, Brian Claggett, et al.
Circulation|September 12, 2014
Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities StudySusan Cheng, Brian Claggett, Andrew W Correia, et al.
European Journal of Heart Failure|February 7, 2015
Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fractionAdriaan A Voors, Mauro Gori, Licette C Y Liu, et al.
Diabetes Care|July 11, 2022
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker StudyHertzel C Gerstein, Sibylle Hess, Brian Claggett, et al.
European Journal of Heart Failure|November 29, 2019
Left atrial structure and function and the risk of death or heart failure in atrial fibrillationRiccardo M Inciardi, Robert P Giugliano, Brian Claggett, et al.
The New England Journal of Medicine|April 27, 2017
Spironolactone Metabolites in TOPCAT - New Insights into Regional VariationSimon de Denus, Eileen O'Meara, Akshay S Desai, et al.
European Journal of Heart Failure|May 23, 2026
Cardiovascular events after acute myocardial infarction complicated by low ejection fraction and/or congestion: a landmark analysis of the PARADISE-MI trialJacinthe Boulet, Jean-Lucien Rouleau, Mark Petrie, et al.
Pageof 37